Characterization of time-related changes after experimental bile duct ligation

British Journal of Surgery

Volumn 95, Issue 5, 2008, Pages 646-656

  Georgiev, P ^a   Jochum, W ^b   Heinrich, S ^a   Jang, J H ^a   Nocito, A ^a   Dahm, F ^a   Clavien, P A ^a,b  

^a Swiss Hepato Pancreato Biliary Center   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; PROCOLLAGEN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; ALKALINE PHOSPHATASE; BILIRUBIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BILE DUCT LIGATION; C57BL 6 MOUSE; CELL COMPARTMENTALIZATION; CELL INFILTRATION; CELL PROLIFERATION; CONFERENCE PAPER; DISEASE COURSE; EXPERIMENTAL SURGERY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KUPFFER CELL; LAPAROTOMY; LIVER; LIVER CELL DAMAGE; LIVER FIBROSIS; LYMPHOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SERUM; TISSUE REACTION; TISSUE REPAIR; ANIMAL; ARTICLE; BILE DUCT; BILIARY CIRRHOSIS; BLOOD; BODY WEIGHT; C57BL MOUSE; LIGATION; LIVER CELL; LIVER DISEASE; MALE; METABOLISM; METHODOLOGY; PATHOLOGY; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; TIME;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANIMALS; BILE DUCTS; BILIRUBIN; BODY WEIGHT; CELL PROLIFERATION; HEPATOCYTES; IMMUNOHISTOCHEMISTRY; LIGATION; LIVER CIRRHOSIS, BILIARY; LIVER DISEASES; MALE; MICE; MICE, INBRED C57BL; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATIONS; TIME FACTORS;

EID: 43549120265     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6050     Document Type: Conference Paper

References (34)

1. Johnstone JM, Lee EG. A quantitative assessment of the structural changes in the rat's liver following obstruction of the common bile duct. Br J Exp Pathol 1976; 57: 85-94.
2. Miyoshi H, Rust C, Roberts PJ, Burgart LJ, Gores GJ. Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. Gastroenterology 1999; 117: 669-677.
3. Canbay A, Higuchi H, Bronk SF, Taniai M, Sebo TJ, Gores GJ et al. Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. Gastroenterology 2002; 123: 1323-1330.
4. Gujral JS, Liu J, Farhood A, Jaeschke H. Reduced oncotic necrosis in Fas receptor-deficient C57BL/6J-lpr mice after bile duct ligation. Hepatology 2004; 40: 998-1007.
5. Wang H, Vohra BP, Zhang Y, Heuckeroth RO. Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice. Hepatology 2005; 42: 1099-1108.
6. Bergheim I, Guo L, Davis MA, Duveau I, Arteel GE. Critical role of plasminogen activator inhibitor-1 in cholestatic liver injury and fibrosis. J Pharmacol Exp Ther 2006; 316: 592-600.
7. Fickert P, Zollner G, Fuchsbichler A, Stumptner C, Weiglein AH, Lammert F et al. Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. Gastroenterology 2002; 123: 1238-1251.
8. Bataller R, Schwabe RF, Choi YH, Yang L, Paik YH, Lindquist J et al. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest 2001; 112: 1383-1394.
9. Yang L, Bataller R, Dulyx J, Coffman TM, Gines P, Rippe RA et al. Attenuated hepatic inflammation and fibrosis in angiotensin type la receptor deficient mice. J Hepatol 2005; 43: 317-323.
10. Isayama F, Hines IN, Kremer M, Milton RJ, Byrd CL, Perry AW et al. LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice. Am J Physiol Gastrointest Liver Physiol 2006; 290: G1318-G1328.
11. Abe T, Arai T, Ogawa A, Hiromatsu T, Matsuda A, Matsuguchi T et al. Kupffer cell-derived interleukin 10 is responsible for impaired bacterial clearance in bile duct-ligated mice. Hepatology 2004; 40: 414-423.
12. Georgiev P, Navarini AA, Eloranta JJ, Lang KS, Kullak-Ublick GA, Nocito A et al. Cholestasis protects the liver from ischaemic injury and post-ischaemic inflammation in the mouse. Gut 2007; 56: 121-128.
13. Liu Z, Sakamoto T, Ezure T, Yokomuro S, Murase N, Michalopoulos G et al. Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type I ductular reaction in mice: interactions between the periductal inflammatory and stromal cells and the biliary epithelium. Hepatology 1998; 28: 1260-1268.
14. Ezure T, Sakamoto T, Tsuji H, Lunz JG III, Murase N, Fung JJ et al. The development and compensation of biliary cirrhosis in interleukin-6-deficient mice. Am J Pathol 2000; 156: 1627-1639.
15. Wang M, Tan Y, Costa RH, Holterman AX. In vivo regulation of murine CYP7A1 by HNF-6: a novel mechanism for diminished CYP7A1 expression in biliary obstruction. Hepatology 2004; 40: 600-608.
16. Canbay A, Guicciardi ME, Higuchi H, Feldstein A, Bronk SF, Rydzewski R et al. Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. J Clin Invest 2003; 112: 152-159.
17. Higuchi H, Bronk SF, Taniai M, Canbay A, Gores GJ. Cholestasis increases tumor necrosis factor-related apoptotis-inducing ligand (TRAIL)-R2/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicity. J Pharmacol Exp Ther 2002; 303: 461-467.
18. Higuchi H, Miyoshi H, Bronk SF, Zhang H, Dean N, Gores GJ. Bid antisense attenuates bile acid-induced apoptosis and cholestatic liver injury. J Pharmacol Exp Ther 2001; 299: 866-873.
19. Lunz JG III, Tsuji H, Nozaki I, Murase N, Demetris AJ. An inhibitor of cyclin-dependent kinase, stress-induced p21Waf-l/Cip-l, mediates hepatocyte mito-inhibition during the evolution of cirrhosis. Hepatology 2005; 41: 1262-1271.
20. Fickert P, Trauner M, Fuchsbichler A, Stumptner C, Zatloukal K, Denk H. Bile acid-induced Mallory body formation in drug-primed mouse liver. Am J Pathol 2002; 161: 2019-2026.
21. Magness ST, Bataller R, Yang L, Brenner DA. A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations. Hepatology 2004; 40: 1151-1159.
22. Kaplan MM, Righetti A. Induction of rat liver alkaline phosphatase: the mechanism of the serum elevation in bile duct obstruction. J Clin Invest 1970; 49: 508-516.
23. Hatoff DE, Hardison WG. Bile acid-dependent secretion of alkaline phosphatase in rat bile. Hepatology 1982; 2: 433-439.
24. Seki E, Tsutsui H, Iimuro Y, Naka T, Son G, Akira S et al. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration. Hepatology 2005; 41: 443-450.
25. Huang W, Ma K, Zhang J, Qatanani M, Cuvillier J, Liv J et al. Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science 2006; 312: 233-236.
26. Liu Z, Sakamoto T, Yokomuro S, Ezure T, Subbotin V, Murase N et al. Acute obstructive cholangiopathy in interleukin-6 deficient mice: compensation by leukemia inhibitory factor (LIF) suggests importance of gp-130 signaling in the ductular reaction. Liver 2000; 20: 114-124.
27. Bird MA, Lange PA, Schrum LW, Grisham JW, Rippe RA, Behrns KE. Cholestasis induces murine hepatocyte apoptosis and DNA synthesis with preservation of the immediate-early gene response. Surgery 2002; 131: 556-563.
28. Pratt DS, Kaplan MM. Evaluation of liver function. In Harrison's Principles of Internal Medicine (16th edn), Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jameson JL (eds). McGraw-Hill: New York, 2005; 1813-1816.
29. Gujral JS, Liu J, Farhood A, Hinson JA, Jaeschke H. Functional importance of ICAM-1 in the mechanism of neutrophil-induced liver injury in bile duct-ligated mice. Am J Physiol Gastrointest Liver Physiol 2004; 286: G499-G507.
30. Gujral JS, Farhood A, Bajt ML, Jaeschke H. Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice. Hepatology 2003; 38: 355-363.
31. Gehring S, Dickson EM, San Martin ME, van Rooijen N, Papa EF, Harty MW et al. Kupffer cells abrogate cholestatic liver injury in mice. Gastroenterology 2006; 130: 810-822.
32. Novobrantseva TI, Majeau GR, Amatucci A, Kogan S, Brenner I, Casola S et al. Attenuated liver fibrosis in the absence of B cells. J Clin Invest 2005; 115: 3072-3082.
33. Wynn TA. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 2004; 4: 583-594.
34. Kountouras J, Billing BH, Scheuer PJ. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol 1984; 65: 305-311.